Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial-Reference-Cited by-同舟云学术

Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial

Published:2020-09-03 Issue:1 Volume:17 Page:101-108
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Makimoto Go¹,Hotta Katsuyuki²^ORCID,Oze Isao³,Ninomiya Kiichiro¹,Nakanishi Masamoto⁴,Hara Naofumi¹,Kano Hirohisa¹,Watanabe Hiromi¹,Hata Yusuke⁵,Nishii Kazuya¹,Nakasuka Takamasa¹,Itano Junko¹,Ninomiya Takashi⁶,Kubo Toshio⁷,Ohashi Kadoaki⁸,Ichihara Eiki⁸,Minami Daisuke⁹,Sato Akiko⁹,Tabata Masahiro⁷,Maeda Yoshinobu¹,Kiura Katsuyuki⁸

Affiliation:

1. Department of Hematology, Oncology, and Respiratory Medicine Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Okayama Japan

2. Center of Innovative Clinical Medicine Okayama University Hospital Okayama Okayama Japan

3. Division of Cancer Epidemiology and Prevention, Department of Preventive Medicine Aichi Cancer Center Research Institute Nagoya Aichi Japan

4. Department of Respiratory Medicine Yamaguchi Ube Medical Center Ube Yamaguchi Japan

5. Department of Respiratory Medicine Kure Kyosai Hospital Kure Hiroshima Japan

6. Health Service Center Okayama University Okayama Okayama Japan

7. Center for Clinical Oncology Okayama University Hospital Okayama Okayama Japan

8. Department of Allergy and Respiratory Medicine Okayama University Hospital Okayama Okayama Japan

9. Department of Respiratory Medicine Okayama Medical Center Okayama Okayama Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13423

Reference28 articles.

1. Meta-Analysis of Randomized Clinical Trials Comparing Cisplatin to Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

2. Long-Standing Debate on Cisplatin- Versus Carboplatin-Based Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer

3. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

4. Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials

5. Association of cisplatin nephrotoxicity with patient characteristics and cisplatin administration methods

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration: A randomized phase II trial;Cancer Medicine;2024-02

2. Hydration Methods for Cisplatin Containing Chemotherapy: A Systematic Review;The Oncologist;2023-11-23

3. Maltol, a naturally occurring flavor enhancer, ameliorates cisplatin-induced apoptosis by inhibiting NLRP3 inflammasome activation by modulating ROS-mediated oxidative stress;Journal of Functional Foods;2022-07

4. The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: an ambispective cohort study;BMC Cancer;2022-04-12

5. Prediction model of acute kidney injury induced by cisplatin in older adults using a machine learning algorithm;PLOS ONE;2022-01-18